Delivery Order SPE2DB22D1202-SPE2DB25FUWJ2

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of a specific medication - the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,186.29 and is a firm fixed price, with an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,817.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of a pharmaceutical product, BREYNA 80-4.5 MCG INHALER 10.3GM, with an ultimate completion date of April 16, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.83 firm-fixed-price delivery order contract is for the supply of a BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $3,067.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical supply product, with an ultimate completion date of December 9, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,011.55, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical products. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,010.16 firm fixed-price delivery order covers the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a performance period through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,799.29, is for the delivery of a specific medical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of April 10, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award, valued at $1,625.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,560.25 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The award is not set-aside and was made under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,197.90, is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a prime vehicle for...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUWJ2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $1,636.44 and is a delivery order contract for the product "BREYNA 80-4.5 MCG INHALER 10.3GM". The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a delivery order against that larger IDC, enabling efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/26/25, 9:50 AM